Literature DB >> 25394966

The 2015 WHO classification of lung tumors.

W D Travis1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25394966     DOI： 10.1007/s00292-014-1974-3

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  47 in total

1.  FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.

Authors:  Fidelis Andrea Flockerzi; Cristiana Roggia; Frank Langer; Bernd Holleczek; Rainer M Bohle
Journal:  Virchows Arch       Date:  2017-12-21       Impact factor: 4.064

Review 2.  Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Authors:  Roberto Chalela; Víctor Curull; César Enríquez; Lara Pijuan; Beatriz Bellosillo; Joaquim Gea
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.

Authors:  Bojin Zhu; Yongjin Yan; Boyun Shao; Luwen Tian; Weihua Zhou
Journal:  J Int Med Res       Date:  2018-01-24       Impact factor: 1.671

Review 4.  Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.

Authors:  Biagio Ricciuti; Clelia Mencaroni; Luca Paglialunga; Francesco Paciullo; Lucio Crinò; Rita Chiari; Giulio Metro
Journal:  Med Oncol       Date:  2016-01-19       Impact factor: 3.064

5.  Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA.

Authors:  Dong-Yao Li; Wen-Jie Chen; Jun Shang; Gang Chen; Shi-Kang Li
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

6.  Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.

Authors:  Jarushka Naidoo; Maria L Santos-Zabala; Tunc Iyriboz; Kaitlin M Woo; Camelia S Sima; John J Fiore; Mark G Kris; Gregory J Riely; Piro Lito; Afsheen Iqbal; Stephen Veach; Stephanie Smith-Marrone; Inderpal S Sarkaria; Lee M Krug; Charles M Rudin; William D Travis; Natasha Rekhtman; Maria C Pietanza
Journal:  Clin Lung Cancer       Date:  2016-01-21       Impact factor: 4.785

7.  TRIM11 promotes tumor angiogenesis via activation of STAT3/VEGFA signaling in lung adenocarcinoma.

Authors:  Jiaru Huang; Laiqin Tang; Yunfeng Zhao; Wei Ding
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

8.  Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.

Authors:  Xifeng Wang; Ziyan Du; Lingyun Li; Minhua Shi; Yong Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.

Authors:  Claudia Pivonello; Panagoula Rousaki; Mariarosaria Negri; Maddalena Sarnataro; Maria Napolitano; Federica Zito Marino; Roberta Patalano; Maria Cristina De Martino; Concetta Sciammarella; Antongiulio Faggiano; Gaetano Rocco; Renato Franco; Gregory A Kaltsas; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2016-09-29       Impact factor: 3.633

10.  Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.

Authors:  Jianhong Zuo; Meiling Wen; Sai Li; Xiu Lv; Lei Wang; Xiaohong Ai; Mingsheng Lei
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.